文献速递妇科

面向未来:结合影像与分子分型预测卵巢癌可切除性的初步研究

Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2022-08-02

该初步研究纳入129例晚期高级别浆液性卵巢癌(HGSOC)患者,术前CT影像评分结合术后肿瘤mRNA分子分型(间充质型占36%,非间充质型占64%)。

要点

  • 高CT评分者更可能为间充质型肿瘤(p=0.014)。
  • 间充质型与高CT评分独立预测宏观残留病灶和高手术复杂度。
  • 术前CT联合分子分型或有助于识别不易切除、需高复杂度手术者。

核心结论

  • 术前CT影像联合肿瘤分子分型可识别不易达到可切除病灶且可能需要高复杂度手术的部分女性。
  • 结合其他临床因素,这些指标可能改进切除预测评分并辅助治疗规划。
  • 研究术前分子分型方法是重要的下一步。

研究设计与样本

  • 初步研究,纳入129例接受术前CT影像及术后肿瘤mRNA分型的HGSOC患者。
  • 基于六项解剖受累影像测量定义反映总体疾病负荷的连续CT评分。
  • 分子分型来自初治肿瘤mRNA谱,分为间充质型(36%)或非间充质型(64%)。
  • 采用Fisher精确检验和多变量逻辑回归分析残留病灶和手术复杂度。

主要发现

  • 高CT评分女性更可能为间充质型肿瘤(p=0.014)。
  • 间充质型和高CT评分独立预测宏观病灶和高手术复杂度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to determine the predictive value of combining tumor molecular subtype and computerized tomography (CT) imaging for surgical outcomes after primary cytoreductive surgery in advanced stage high-grade serous ovarian cancer (HGSOC) patients. METHODS: We identified 129 HGSOC patients who underwent pre-operative CT imaging and post-operative tumor mRNA profiling. A continuous CT-score indicative of overall disease burden was defined based on six imaging measurements of anatomic involvement. Molecular subtypes were derived from mRNA profiling of chemo-naïve tumors and classified as mesenchymal (MES) subtype (36%) or non-MES subtype (64%). Fischer exact tests and multivariate logistic regression examined residual disease and surgical complexity. RESULTS: Women with higher CT-scores were more likely to have MES subtype tumors (p = 0.014). MES subtypes and a high CT-score were independently predictive of macroscopic disease and high surgical complexity. In multivariate models adjusting for age, stage and American Society of Anesthesiologists (ASA) score, patients with a MES subtype and high CT-score had significantly elevated risk of macroscopic disease (OR = 26.7, 95% CI = [6.42, 187]) and were more likely to undergo high complexity surgery (OR = 9.53, 95% CI = [2.76, 40.6], compared to patients with non-MES tumor and low CT-score. CONCLUSION: Preoperative CT imaging combined with tumor molecular subtyping can identify a subset of women unlikely to have resectable disease and likely to require high complexity surgery. Along with other clinical factors, these may refine predictive scores for resection and assist treatment planning. Investigating methods for pre-surgical molecular subtyping is an important next step.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kumar A, Wang C, Sheedy SP, et al. Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer. Gynecol Oncol. 2022. PMID: 35931468. doi:10.1016/j.ygyno.2022.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。